从生物活性化合物库中发现B型肝炎病毒亚病毒粒子生物发生抑制剂
Biplav Shrestha1, Sisi Yang2, Lauren Griffith1
1Baruch S. Blumberg Institute, Doylestown, PA, USA.
Antiviral research
|July 4, 2024
概括
治疗消除乙型肝炎表面抗原 (HBsAg) 可能可以治愈慢性乙型肝炎. 研究人员选了化合物,发现利科林有效降低了HBsAg,为慢性HBV感染提供了潜在的新治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 高水平的乙型肝炎病毒表面抗原 (HBsAg) 会导致T和B细胞衰竭,持续感染.
- 治疗性消除HBsAg可能会激活免疫反应,从而对慢性乙型肝炎有功能治愈.
- HBV S 蛋白质的两性阿尔法螺旋 (W156-R169) 对于亚病毒粒子 (SVP) 形态发生和S 蛋白质代谢至关重要.
研究的目的:
- 为了确定SVP生物发生的药理抑制剂,以减少HBsAg分泌.
- 研究破坏SVP形态发生的潜力,用于治疗慢性乙型肝炎.
- 确定莱科林对抗HBV的抗病毒机制和结构-活性关系.
主要方法:
- 使用表达HBV S蛋白的HepG2细胞系选了4417种生物活性化合物.
- 评估化合物对细胞内SVP和分泌的HBsAg的影响.
- 对HBV复制体转移的HepG2细胞和表达NTCP的HBV感染的HepG2细胞评估了利科林的疗效.
主要成果:
- 确定了24种化合物,可以减少细胞内SVP,并分泌HBsAg.
- 18种化合物抑制了HBsAg和HBeAg的分泌,这表明正常细胞功能受到干扰.
- 莱科林在各种HBV模型中显示出对HBsAg分泌的强烈抑制.
结论:
- 对SVP形态发生的药理学干扰是减少HBsAg的可行策略.
- 莱科林是开发针对慢性乙型肝炎的新疗法的一个有希望的候选者.
- 对莱科林的抗病毒机制和结构-活性关系的进一步研究是有必要的.
相关概念视频
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


